Clinical Trial Update: Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjuvant leuprolide with or without docetaxel after radical prostatectomy in high-risk prostate cancer; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Lupron (leuprolide)
• Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Prostatic Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2012-01-23